| NDI | nephrogenic diabetes insipidus |
|---|---|
| NDIR | nondispersive infrared analyzer |
| NDMA | nitrosodimethylamine |
| NDMR | nondepolarizing muscle relaxant |
| nDNA | nuclear deoxyribonucleic acid |
| NDP | net dietary protein; nucleoside diphosphate |
| NDPK | nucleoside diphosphate kinase |
| NDPKA | nucleoside diphosphate kinase A |
| NDPKB | nucleoside diphosphate kinase B |
| NDR | neonatal death rate; normal detrusor reflex |
| NDCM | Nocardia delipidated Cell Mitogen |
|---|---|
| NDDG | National Diabetes Data Group |
| NDE | Near-Death Experience |
| NDEA | N-nitroso-N,N-diethylamine |
| NDELA | N'nitroso-diethanolamine |
| NDF | Neu differentiation factor |
| NDF | Neutral detergent fiber |
| NDF | Neutral detergent fibre |
| NDGA | Nordihydrogaiaretic acid |
| NDI | National Death Index |
| NDA |
New Drug Application. A large document that contains all required data on the safety and efficacy of a new drug product. The NDA must be submitted to the FDA for approval before the product can be sold in the US
출처: www.drscholls.com/content/info/glossary.htm
|
|---|---|
| NDA |
following phase III of clinical testing, the drug sponsor applies for a new drug application, which is reviewed by the FDA. If the FDA finds the results favorable, the drug company can market the drug for conditions/ diseases, which are applicable to phase testing results.
출처: www.therubins.com/geninfo/Definit.htm
|
| Nd |
North Dakota - Bismarck
출처: www.politicalinformation.net/encyclopedia/States_o...
|
| NDA |
New Drug Application, a complete application (typically thousands of pages long) to the FDA (Food and Drug Administration) to begin marketing of a drug product in the US.
출처: www.genelabs.com/resources/glossary.html
|
| Nd |
No Date; no publication date is supplied in the book.
출처: www.ioba.org/terms.html
|